Response to O'Shea and Colado: the MDMA neurotoxicity profile might provide clues to mechanisms

Author： Ricaurte G.A.   Yuan J.   Hatzidimitriou G.   Cord B.J.   McCann U.D.  

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.24, Iss.6, 2003-06, pp. : 275-275

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neurotoxicity of Ecstasy (MDMA): An Overview

By  

Current Pharmaceutical Biotechnology, Vol. 11, Iss. 5, 2010-08 ,pp. : 460-469

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial note: MDMA-induced dopamine neurotoxicity

By Warburton David  

Psychopharmacology, Vol. 171, Iss. 2, 2004-01 ,pp. : 228-228

Springer Publishing Company

Access to resources Recommend Favorite

Response to: Parrott AC, Buchanan T, Heffernan TM, Scholey A, Ling J, Rodgers J (2003) Parkinson’s disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users. Psychopharmacology 167(4):449–450

By Sumnall H.   Jerome L.   Doblin R.   Mithoefer M.  

Psychopharmacology, Vol. 171, Iss. 2, 2004-01 ,pp. : 229-230

Springer Publishing Company

Access to resources Recommend Favorite

3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings

By Baumann Michael   Wang Xiaoying   Rothman Richard  

Psychopharmacology, Vol. 189, Iss. 4, 2007-01 ,pp. : 407-424

Springer Publishing Company

Access to resources Recommend Favorite

MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment

By Verrico Christopher   Miller Gregory   Madras Bertha  

Psychopharmacology, Vol. 189, Iss. 4, 2007-01 ,pp. : 489-503

Springer Publishing Company

Access to resources Recommend Favorite